SOLAI LTD (SLAI)
SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND
SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND
OSI Systems Receives $19 Million Order to Support Deployment of Non-Intrusive Inspection Solutions
Servier projette dacquérir lactivité dystrophie musculaire dEdgewise Therapeutics USA - Français USA - English USA - English
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 2Q26
Servier to Acquire Edgewise Therapeutics Muscular Dystrophy Business USA - English USA - English USA - Français
Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026
Cintas Earns Spot on Forbes America’s Best Employers for New Grads 2026 List
Amprius Sets June 2026 Events Schedule